Hyperglycemia and nocturnal systolic blood pressure are associatedwith left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients

Felício, João S.; Pacheco, Juliana T.; Ferreira, Sandra R.; Plavnik, Frida; Moisés, Valdir A.; Kohlmann Jr., Oswaldo; Ribeiro, Artur B.; Zanella, Maria T.
January 2006
Cardiovascular Diabetology;2006, Vol. 5, p19
Academic Journal
Background: The aim of this study was to determine if hypertensive type 2 diabetic patients, when compared to patients with essential hypertension have an increased left ventricular mass index (LVMI) and a worse diastolic function, and if this fact would be related to 24-h pressoric levels changes. Methods: Ninety-one hypertensive patients with type 2 diabetes mellitus (DM) (group-1 [G1]), 59 essential hypertensive patients (group-2 [G2]) and 26 healthy controls (group-3 [G3]) were submitted to 24-h Ambulatory Blood Pressure Monitoring (ABPM) and echocardiography (ECHO) with Doppler. We calculated an average of fasting blood glucose (AFBG) values of G1 from the previous 4.2 years and a glycemic control index (GCI) (percentual of FBG above 200 mg/dl). Results: G1 and G2 did not differ on average of diurnal systolic and diastolic BP. However, G1 presented worse diastolic function and a higher average of nocturnal systolic BP (NSBP) and LVMI (NSBP = 132 ± 18 vs 124 ± 14 mmHg; P < 0.05 and LVMI = 103 ± 27 vs 89 ± 17 g/m2; P < 0.05, respectively). In G1, LVMI correlated with NSBP (r = 0.37; P < 0.001) and GCI (r = 0.29; P < 0.05) while NSBP correlated with GCI (r = 0.27; P < 0.05) and AFBG (r = 0.30; P < 0.01). When G1 was divided in tertiles according to NSBP, the subgroup with NSBP=140 mmHg showed a higher risk of LVH. Diabetics with NSBP=140 mmHg and AFBG>165 mg/dl showed an additional risk of LVH (P < 0.05; odds ratio = 11). In multivariate regression, both GCI and NSBP were independent predictors of LVMI in G1. Conclusion: This study suggests that hyperglycemia and higher NSBP levels should be responsible for an increased prevalence of LVH in hypertensive patients with Type 2 DM.


Related Articles

  • Hyperglycemia enhances function and differentiation of adult rat cardiac fibroblasts1. Shamhart, Patricia E.; Luther, Daniel J.; Adapala, Ravi K.; Bryant, Jennifer E.; Petersen, Kyle A.; Meszaros, J. Gary; Thodeti, Charles K // Canadian Journal of Physiology & Pharmacology;Jul2014, Vol. 92 Issue 7, p598 

    Diabetes is an independent risk factor for cardiovascular disease that can eventually cause cardiomyopathy and heart failure. Cardiac fibroblasts (CF) are the critical mediators of physiological and pathological cardiac remodeling; however, the effects of hyperglycemia on cardiac fibroblast...

  • Identification of Amadori-Modified Plasma Proteins in Type 2 Diabetes and the Effect of Short-Term Intensive Insulin Treatment. Jaleel, Abdul; Halvatsiotis, Panagiotis; Williamson, Brian; Juhasz, Peter; Martin, Stephen; Nair, K. Sreekumaran // Diabetes Care;Mar2005, Vol. 28 Issue 3, p645 

    OBJECTIVE -- Growing evidence supports that nonenzymatic glycation products may cause hyperglycemia-induced diabetes complications. Amadori-modified proteins are the intermediate products of nonenzymatic glycation and constitute the forms of glycated proteins in diabetes. The objective of the...

  • Diabetes Mellitus. Joost, Hans-Georg; Schürmann, Annette // Encyclopedic Reference of Molecular Pharmacology;2004, p298 

    A definition of the term "diabetes mellitus" is presented. It refers to hyperglycemia due to absolute or relative lack of insulin. Basic mechanisms associated to diabetes mellitus are discussed. A chart is presented that lists the pharmakokinefic characteristics of the most commonly used insulin...

  • sulfonylurea.  // Taber's Cyclopedic Medical Dictionary;2005, p2105 

    The article presents a definition for the term "sulfonylurea," which refers to one of a class of oral drugs used to control hyperglycemia in type 2 diabetes mellitus. Members of this group include tolazamide, glyburide, and glipizide.

  • Treatment of Hypertension in Type 2 Diabetes. Padilla, Ricardo; Mehler, Philip S. // Journal of Women's Health & Gender-Based Medicine;Nov2001, Vol. 10 Issue 9, p897 

    Hypertension is one of the most common medical conditions in the United States, affecting 50 million American adults and accounting for one of four physician office visits. It is often undetected and undertreated, creating significant public health consequences. In diabetes, hypertension is an...

  • Hyperosmular non-ketotic diabetes mellitus associated with metolazone. Mather, H.G. // British Medical Journal (Clinical Research Edition);7/6/1985, Vol. 291 Issue 6487, p25 

    Focuses on hyperosmolar non-ketotic diabetes mellitus associated with metolazone. Highlights of the propensity of other thiazides; Admission of a 64 year old woman with heavy glycosuria, nausea and vomiting; History of hypertension treated with metolazone; Association of adrenergic blocking...

  • Dyslipidaemia and hypertension among adults with diabetes in rural Uganda. Kamara, Nicholas Thadeus; Asiimwe, Stephen // Tropical Doctor;Jan2009, Vol. 40 Issue 1, p41 

    Dyslipidaemia and hypertension in patients with diabetes increase the risk of macrovascular and microvascular complications. We took anthropometric measurements, lipids, blood pressure and fasting blood sugar of 150 diabetics and 151 non-diabetics. Among the diabetics, 17 (11.3%) had total...

  • Betamethasone.  // Reactions Weekly;12/1/2007, Issue 1180, p6 

    The article presents several medical cases of pregnant women with complicated, poorly controlled diabetes mellitus who experienced various toxicities following treatment with betamethasone. One patient with hypertension and type 1 diabetes mellitus had previously had a fetus die at 31 weeks'...

  • Sitting time and health outcomes among Mexican origin adults: obesity as a mediator. de Heer, Hendrik D.; Wilkinson, Anna V.; Strong, Larkin L.; Bondy, Melissa L.; Koehly, Laura M. // BMC Public Health;2012, Vol. 12 Issue 1, p896 

    Background: Sitting time and sedentary behaviors have been associated with adverse health outcomes including obesity, diabetes and cardiovascular disease (CVD) within non- Hispanic White populations. Similar associations have not been described within Hispanic populations despite their high CVD...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics